Short answer · Medically reviewed summary · Last updated: 2023-07-13
Megalencephalic Leukoencephalopathy With Subcortical Cysts (MLC) is a rare genetic disorder that affects the brain's white matter. It is characterized by the presence of subcortical cysts and abnormal enlargement of the brain (megalencephaly).
What is the prevalence of Megalencephalic Leukoencephalopathy With Subcortical Cysts?
Prevalence of Megalencephalic Leukoencephalopathy With Subcortical Cysts: how many people are affected worldwide, differences by sex and region, with sources.
Megalencephalic Leukoencephalopathy With Subcortical Cysts (MLC) is a rare genetic disorder that affects the brain's white matter. It is characterized by the presence of subcortical cysts and abnormal enlargement of the brain (megalencephaly). MLC primarily manifests in early childhood, typically between the ages of 1 and 5 years.
The prevalence of MLC is estimated to be very low, with only a few hundred cases reported worldwide. Due to its rarity, the exact prevalence is difficult to determine accurately. MLC has been reported in various populations, including individuals of different ethnic backgrounds.
MLC is an autosomal recessive disorder, meaning that both parents must carry a mutated gene for their child to be affected. The specific genetic mutations associated with MLC have been identified in the MLC1 and MLC2A genes.
Individuals with MLC may experience a range of symptoms, including motor difficulties, cognitive impairment, seizures, and progressive neurological deterioration. The severity and progression of the disease can vary among affected individuals.
Early diagnosis and appropriate management are crucial in improving the quality of life for individuals with MLC. Genetic counseling and supportive therapies can help manage symptoms and provide necessary support to affected individuals and their families.
